| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 06/07/2011 | CA2360624C Formulation of herbicides and plant growth regulators |
| 06/03/2011 | WO2011066545A1 Treatment of human osteosarcoma |
| 06/03/2011 | WO2011066179A1 Novel compounds as receptor modulators with therapeutic utility |
| 06/03/2011 | WO2011066168A1 Potassium channel modulators |
| 06/03/2011 | WO2011065402A1 Indole compound and pharmaceutical use thereof |
| 06/03/2011 | WO2009016466A3 A process for the preparation of naratriptan hydrochloride |
| 06/03/2011 | CA2781660A1 Indole compound and pharmaceutical use thereof |
| 06/03/2011 | CA2780908A1 Novel compounds as receptor modulators with therapeutic utility |
| 06/03/2011 | CA2778266A1 Potassium channel modulators |
| 06/02/2011 | US20110130570 Novel Form of S-Omeprazole |
| 06/02/2011 | US20110130426 Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases |
| 06/02/2011 | US20110130424 Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties |
| 06/02/2011 | US20110130423 Compounds Which Have Activity At M1 Receptor And Their Uses In Medicine |
| 06/02/2011 | US20110130419 Novel salt of isoquinoline compound and crystal thereof |
| 06/02/2011 | US20110130418 Substituted phenylenediamines as inhibitors of the interaction between mdm2 and p53 |
| 06/02/2011 | US20110130415 Protein kinase c inhibitors and uses thereof |
| 06/02/2011 | US20110130409 Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders |
| 06/02/2011 | US20110130408 Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists |
| 06/02/2011 | US20110130407 Isoquinolinone derivatives as nk3 antagonists |
| 06/02/2011 | US20110130401 New chemical compounds |
| 06/02/2011 | US20110130399 Phthalazine Derivatives with Angiogenesis Inhibiting Activity |
| 06/02/2011 | US20110130398 Spiroindolinone pyrrolidines |
| 06/02/2011 | US20110130394 Pharmaceutical compounds |
| 06/02/2011 | US20110130391 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 06/02/2011 | US20110130385 Bicyclic Heterocylic Derivatives and Methods of Use |
| 06/02/2011 | US20110130380 Heteroaryl Kinase Inhibitors |
| 06/02/2011 | US20110130379 Piperazine derivatives used as cav2.2 calcium channel modulators |
| 06/02/2011 | US20110130365 Fluorinated Heteroaryls |
| 06/02/2011 | US20110130286 Piperazine Compounds with Herbicidal Effect |
| 06/02/2011 | US20110129678 Photochromic compounds and compositions |
| 06/02/2011 | US20110129624 Novel azomethine compound and thermal transfer sheet using coloring matter of the azomethine compound |
| 06/02/2011 | US20110129549 Tricyclic benzo[5,6]cyclohepta[1,2-b]pyridine derivatives and uses thereof |
| 06/02/2011 | US20110129542 Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1 |
| 06/02/2011 | US20110129419 In vivo imaging agents |
| 06/02/2011 | US20110127496 Neutral Metallic Dendrimer Complexes |
| 06/01/2011 | EP2327701A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 06/01/2011 | EP2327700A1 Dialkyl triazinamines and use thereof for combating undesired plant growth |
| 06/01/2011 | EP2327693A1 Indoles and their therapeutic use |
| 06/01/2011 | EP2327692A1 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-)aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors |
| 06/01/2011 | EP2327679A2 Novel anthracene derivatives and organic electronic device using same |
| 06/01/2011 | EP2326640A1 Pyrrole carboxylic acid derivatives as antibacterial agents |
| 06/01/2011 | EP2326639A1 Substituted pyridines, and use thereof as gsk3 inhibitors |
| 06/01/2011 | EP2326638A1 Diazepine and diazocane compounds as mc4 agonists |
| 06/01/2011 | EP2326637A2 Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium |
| 06/01/2011 | EP2326636A2 Pyrazole carboxamide inhibitors of factor xa |
| 06/01/2011 | EP2326629A1 Sulfone compounds which modulate the cb2 receptor |
| 06/01/2011 | EP2326627A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 06/01/2011 | EP2326625A1 Benzazepine derivatives and their use as hstamine h3 antagonists |
| 06/01/2011 | EP2326623A2 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| 06/01/2011 | EP2326621A1 SUBSTITUTED 1,2,3,4- TETRAHYDROCYCLOPENTA[b]INDOL-3-YL) ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS |
| 06/01/2011 | EP1981854B1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 06/01/2011 | EP1716135B1 Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists |
| 06/01/2011 | EP1379510B1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chemosensitizers |
| 06/01/2011 | EP1337525B1 Process for the crystallization of (r)- or (s)-lansoprazole |
| 06/01/2011 | DE102010002558A1 Verwendung physiologischer Kühlwirkstoffe und Mittel enthaltend solche Wirkstoffe The use of physiological cooling agents and compositions comprising such agents |
| 06/01/2011 | CN201848117U Glass device for extracting and separating active ingredients from cigarette factory materials |
| 06/01/2011 | CN1875016B Imidazole derivatives |
| 06/01/2011 | CN102083824A Method of treating cancer using a cMET and AXL inhibitor and an ErbB inhibitor |
| 06/01/2011 | CN102083819A Novel phenylpyrazinones as kinase inhibitors |
| 06/01/2011 | CN102083818A Substituted 1-(diazinyl) pyrazole-4-yl-acetic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators |
| 06/01/2011 | CN102083817A Compounds and compositions as ITPKB inhibitors |
| 06/01/2011 | CN102083816A Fungicide hydroximoyl-tetrazole derivatives |
| 06/01/2011 | CN102083815A Fungicide hydroximoyl-tetrazole derivatives |
| 06/01/2011 | CN102083814A Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same |
| 06/01/2011 | CN102083813A Piperidinyl gpcr agonists |
| 06/01/2011 | CN102083812A Muscarinic receptor agonits useful in the treatment of pain, alzheimer's disease and schizophrenia |
| 06/01/2011 | CN102083811A 2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors |
| 06/01/2011 | CN102083800A Heteroaryl compounds and uses thereof |
| 06/01/2011 | CN102083799A Benzimidazole derivatives used as FXR agonists |
| 06/01/2011 | CN102083797A Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy |
| 06/01/2011 | CN102083794A Urea compounds as gamma secretase modulators |
| 06/01/2011 | CN102083793A Protease inhibitors |
| 06/01/2011 | CN102082230A Infrared organic electroluminescent device |
| 06/01/2011 | CN102079744A Deuterated achiral crizotinib and derivatives, preparation method and application thereof |
| 06/01/2011 | CN102079743A Dipeptidyl peptidase inhibitors |
| 06/01/2011 | CN101537746B Heat resistance improver and reversible thermosensitive recording medium |
| 06/01/2011 | CN101432262B Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 06/01/2011 | CN101379036B Anthranilamide/2-amino-heteroarene carboxamide derivatives |
| 06/01/2011 | CN101175729B 1-phenyl-3-piperazine-pyrazoles and pesticidal compositions of matter thereof |
| 05/31/2011 | US7951958 Imidazole compounds for the treatment of neurodegenerative disorders |
| 05/31/2011 | US7951957 Substituted benzimidazoles and their use for inducing apoptosis |
| 05/31/2011 | US7951955 Antiviral agents |
| 05/31/2011 | US7951953 Conversion of 2-pyrazolines to pyrazoles using bromine |
| 05/31/2011 | US7951830 Compounds effecting glucokinase |
| 05/31/2011 | US7951826 Obesity; cognition activators; narcolepsy |
| 05/31/2011 | US7951825 Hetero compound |
| 05/31/2011 | US7951824 4-aryl-pyridine-2-carboxyamide derivatives |
| 05/31/2011 | US7951820 Triazole compounds useful as protein kinase inhibitors |
| 05/31/2011 | US7951809 Inhibitors of p38 |
| 05/31/2011 | US7951808 Imidazole compounds |
| 05/31/2011 | US7951807 Substituted oxindol derivatives and medicaments containing the same |
| 05/31/2011 | US7951805 Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase |
| 05/31/2011 | US7951804 Inhibitors of coagulation factors; Thrombosis, tumors, myocardial infarction, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis; example, 1-(4-chlorophenyl)-3-[2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-1-phenylethyl]urea |
| 05/31/2011 | US7951802 Use of 7-azaindoles in the inhibition of c-Jun N-terminal kinase |
| 05/31/2011 | US7951796 9-amino-acridine derivatives and their use for eliminating misfolded proteins |
| 05/31/2011 | CA2555745C Tetrahydroisoquinoline-and tetrahydrobenzazepine derivatives as igf-1r inhibitors |
| 05/31/2011 | CA2533515C Heteroaryl-tetrahydropyridyl compounds useful for treating or preventing pain |
| 05/31/2011 | CA2507657C 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists |
| 05/31/2011 | CA2501734C Novel bicyclic inhibitors of hormone sensitive lipase |
| 05/31/2011 | CA2475764C New inhibitors of histone deacetylase |